Literature DB >> 6284912

Effect of sodium orthovanadate on renal renin secretion in vivo.

J M López Novoa, J C García, M A Cruz-Soto, J E Benabe, M Martínez-Maldonado.   

Abstract

The effect of vanadate (0.5 mumol/min) on renin secretory rate (RSR) of the kidney has been studied in nembutal-anesthetized, volume-expanded dogs. Intrarenal vanadate infusion caused a 69.3 +/- 8.8% decrease in RSR. This was accompanied by marked decreases in renal blood flow (RBF), glomerular filtration rate (GFR) and fractional excretion of sodium (FENa). Renal vascular resistance rose from 1.3 +/- 0.09 to 6.1 +/- 2.3 mm Hg/ml/min (P less than .0005). Papaverine infusion partially blunted the effect of vanadate on RSR (RSR only fell to 42. +/- 10% of basal values). The decreases in RBF and GFR were also less and FENa slightly higher than normal. Acetylcholine prevented the effects of vanadate more fully. There was no fall in RBF, GFR or FENa and it basically abolished the fall in RSR which fell only 19.4 +/- 25.3 of control (P = N.S.). Nifedipine (a slow Ca++ channels blocker) also prevented the fall in RBF, GFR and FENa induced by vanadate. RSR did not change significantly (7.8 +/- 10.9%). These results clearly demonstrate that vanadate is a potent inhibitor of renin secretion and suggest that inhibition of smooth muscle Na+, K+, adenasine triphosphatase and changes in the cystosolic concentration of Na and Ca are involved in its mechanism. Changes in perfusion pressure and sodium delivery to the macula densa appear to have little if any role in the inhibition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284912

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Intracellular control of renin release--an overview.

Authors:  A Kurtz
Journal:  Klin Wochenschr       Date:  1986-09-15

2.  Peripheral erythrocyte levels, hemolysis and three vanadium compounds.

Authors:  G R Hogan
Journal:  Experientia       Date:  1990-05-15

3.  Subchronic treatment with vanadate does not potentiate the toxicity of cardiac glycosides.

Authors:  E MacDonald; H Lihtamo; K Hellevuo; H Komulainen
Journal:  Biol Trace Elem Res       Date:  1988-08       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.